CPP, mmHg | |||||||
---|---|---|---|---|---|---|---|
Pericontusional | < 40 | 40 to 50 | 50 to 60 | 60 to 70 | 70 to 80 | 80 to 90 | > 90 |
Glucose, mM/l | 0.5 ± 0.7 | 1.0 ± 1.2 | 1.5 ± 1.4 | 1.7 ± 1.4 | 2.0 ± 1.6 | 2.2 ± 1.6 | 2.1 ± 1.4 |
Lactate, mM/l | 11 ± 6.3 | 5.0 ± 3.6 | 5.3 ± 2.6 | 5.3 ± 2.7 | 5.2 ± 2.6 | 5.0 ± 2.5 | 4.8 ± 2.8 |
Pyruvate, μM/l | 253 ± 190 | 263 ± 348 | 147 ± 85 | 166 ± 83 | 171 ± 89 | 177 ± 85 | 178 ± 89 |
Glycerol, μM/l | 307 ± 312 | 166 ± 213 | 258 ± 303 | 240 ± 374 | 262 ± 430 | 247 ± 377 | 315 ± 422 |
LP ratio | 45 ± 20 | 55 ± 117 | 61 ± 105 | 46 ± 78 | 45 ± 74 | 36 ± 49 | 28 ± 14 |
LG ratio | 105 ± 70 | 31 ± 43 | 15 ± 25 | 8.9 ± 19 | 5.6 ± 12 | 3.6 ± 3.4 | 4.6 ± 9.4 |
Number of samples (n 64 patients) | 45 | 67 | 825 | 1,992 | 1,576 | 646 | 388 |
Nonpericontusional | |||||||
Glucose, mM/l | 1.2 ± 0.7 | 1.6 ± 0.9 | 2.0 ± 1.3 | 1.7 ± 1.4 | 1.7 ± 1.5 | 2.1 ± 1.6 | 2.6 ± 1.4 |
Lactate, mM/l | 4.8 ± 1.1 | 4.1 ± 1.6 | 3.8 ± 2.1 | 4.1 ± 2.7 | 4.4 ± 2.9 | 4.1 ± 2.2 | 4.3 ± 1.5 |
Pyruvate, μM/l | 162 ± 52 | 151 ± 58 | 155 ± 73 | 155 ± 61 | 161 ± 62 | 165 ± 58 | 188 ± 57 |
Glycerol, μM/l | 309 ± 410 | 327 ± 513 | 356 ± 462 | 294 ± 415 | 190 ± 242 | 186 ± 213 | 144 ± 170 |
LP ratio | 36 ± 25 | 28 ± 8.7 | 25 ± 14 | 28 ± 24 | 29 ± 24 | 25 ± 9.4 | 23 ± 7.1 |
LG ratio | 5.2 ± 2.6 | 4.6 ± 6.4 | 4.5 ± 8.4 | 8.2 ± 19 | 9.6 ± 22 | 5.6 ± 11 | 3.7 ± 5.9 |
Number of patients (n 26 patients) | 47 | 130 | 372 | 571 | 375 | 142 | 65 |